Medically reviewed by Drugs.com. Last updated on May 28, 2021.
Generic name: Diclofenac Epolamine 0.013g
Dosage form: topical system
Important Dosage and Administration Information
Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5)].
LICART is intended for topical use only.
Convey the following important administration instructions to the patient:
- If LICART begins to peel-off, the edges of the topical system may be taped down. If problems with adhesion persist, patients may overlay the topical system with a mesh netting sleeve, where appropriate (e.g., to secure topical systems applied to ankles, knees, or elbows). The mesh netting sleeve (e.g., Curad® Hold Tite™, Surgilast® Tubular Elastic Dressing) must allow air to pass through and not be occlusive (i.e., non-breathable)1.
- Do not apply LICART to non-intact or damaged skin resulting from any etiology, e.g., exudative dermatitis, eczema, infected lesion, burns or wounds.
- Do not wear a LICART topical system when bathing or showering.
- Wash your hands after applying, handling, or removing the topical system.
- Avoid contact with eyes.
- Do not use LICART in combination with an oral NSAID unless the benefit outweighs the risk and periodic laboratory evaluations are conducted.
- Curad® Hold Tite™ is a trademark of Medline Industries, Inc., and Surgilast® Tubular Elastic Dressing is a trademark of Derma Sciences, Inc.
More about Licart (diclofenac topical)
- Side Effects
- During Pregnancy or Breastfeeding
- Drug Interactions
- Pricing & Coupons
- Drug class: topical non-steroidal anti-inflammatories